Nifty

:

22419.95

Sensex

:

73730.16

-150.40 (-0.67%)
-609.28 (-0.82%)

Login

Nifty
Sensex

:
:

22419.95
73730.16

-150.40 (-0.67%)
-609.28 (-0.82%)

Medico Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

47/99

BSE: 540937 | NSE: MEDICO

Watchlist

NSE BSE

46.25

26-Apr-2024

Open
High
Low
Previous Close

46.75
47.30
46.00
46.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

80133
37.12
100.70
44.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

386.29
55.51
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

390.60
N/A
7.88

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.09
7.53
4.69

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.73
27.99
12.59

PAT CAGR (%)

10 Years
5 Years
3 Years

27.66
35.76
40.87

P:E (Median)

8 Years
5 Years
3 Years

-
75.83
81.08

P:BV (Average)

8 Years
5 Years
3 Years

-
9.59
10.30

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
37.65
40.93

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 29.77 38.85 -23.37% 42.36 40.46 4.70% 31.47 33.14 -5.04% 27.99 32.28 -13.29%
Expenses 27.04 35.46 -23.75% 39.28 37.31 5.28% 29.01 33.32 -12.94% 24.83 29.63 -16.20%
EBITDA 2.73 3.39 -19.47% 3.08 3.15 -2.22% 2.46 -0.18 - 3.16 2.64 19.70%
EBIDTM 9.18% 8.72% 7.26% 7.78% 7.80% -0.56% 11.30% 8.19%
Other Income 0.27 0.86 -68.60% 0.96 1.55 -38.06% 0.31 1.60 -80.62% 0.04 0.74 -94.59%
Interest 0.22 0.20 10.00% 0.18 0.17 5.88% 0.17 0.17 0.00% 0.21 0.13 61.54%
Depreciation 0.72 0.74 -2.70% 0.71 0.66 7.58% 0.71 0.59 20.34% 0.73 0.88 -17.05%
PBT 2.06 3.31 -37.76% 3.14 3.86 -18.65% 1.88 0.65 189.23% 2.27 2.37 -4.22%
Tax 0.62 1.07 -42.06% 0.72 0.99 -27.27% 0.56 0.29 93.10% 0.51 0.49 4.08%
PAT 1.44 2.25 -36.00% 2.43 2.87 -15.33% 1.32 0.36 266.67% 1.77 1.88 -5.85%
PATM 4.85% 5.79% 5.73% 7.09% 4.20% 1.08% 6.31% 5.83%
EPS 0.17 0.27 -37.04% 0.29 0.35 -17.14% 0.16 0.04 300.00% 0.21 0.23 -8.70%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 131.59 140.44 121.02 122.39 88.64 97.69 61.02 54.42 66.68 50.99 44.86 Net Sales Growth -9.08% 16.05% -1.12% 38.08% -9.26% 60.10% 12.13% -18.39% 30.77% 13.66% Cost Of Goods Sold 99.81 88.33 70.74 79.37 57.38 67.79 33.50 29.35 53.00 39.24 34.54 Gross Profit 31.78 52.11 50.29 43.02 31.25 29.90 27.52 25.07 13.68 11.76 10.32 GP Margin 24.15% 37.10% 41.56% 35.15% 35.25% 30.61% 45.10% 46.07% 20.52% 23.06% 23.00% Total Expenditure 120.16 130.96 113.69 117.15 85.80 94.93 57.54 50.41 63.03 48.09 42.66 Power & Fuel Cost - 2.47 2.29 1.91 1.83 1.73 1.42 1.05 0.00 0.00 0.00 % Of Sales - 1.76% 1.89% 1.56% 2.06% 1.77% 2.33% 1.93% 0% 0% 0% Employee Cost - 5.68 5.41 4.50 3.83 3.32 3.89 4.42 4.25 3.41 2.42 % Of Sales - 4.04% 4.47% 3.68% 4.32% 3.40% 6.37% 8.12% 6.37% 6.69% 5.39% Manufacturing Exp. - 22.36 23.00 18.02 15.00 16.03 13.73 11.00 0.00 0.00 0.00 % Of Sales - 15.92% 19.01% 14.72% 16.92% 16.41% 22.50% 20.21% 0% 0% 0% General & Admin Exp. - 1.97 2.12 2.38 2.20 1.49 1.33 1.49 5.77 5.44 5.71 % Of Sales - 1.40% 1.75% 1.94% 2.48% 1.53% 2.18% 2.74% 8.65% 10.67% 12.73% Selling & Distn. Exp. - 9.60 9.03 8.30 4.80 3.86 2.82 2.69 0.00 0.00 0.00 % Of Sales - 6.84% 7.46% 6.78% 5.42% 3.95% 4.62% 4.94% 0% 0% 0% Miscellaneous Exp. - 0.54 1.10 2.67 0.75 0.71 0.84 0.41 0.00 0.00 0.00 % Of Sales - 0.38% 0.91% 2.18% 0.85% 0.73% 1.38% 0.75% 0% 0% 0% EBITDA 11.43 9.48 7.33 5.24 2.84 2.76 3.48 4.01 3.65 2.90 2.20 EBITDA Margin 8.69% 6.75% 6.06% 4.28% 3.20% 2.83% 5.70% 7.37% 5.47% 5.69% 4.90% Other Income 1.58 4.09 2.03 1.03 2.10 1.90 0.91 0.36 0.24 0.11 0.12 Interest 0.78 0.75 0.66 0.92 1.06 0.98 1.52 1.33 0.85 0.82 0.61 Depreciation 2.87 2.72 2.22 1.65 1.66 1.51 1.00 1.05 1.18 1.09 0.75 PBT 9.35 10.10 6.48 3.70 2.22 2.18 1.87 1.99 1.87 1.10 0.96 Tax 2.41 2.86 1.67 1.11 0.58 0.60 0.65 0.06 0.74 0.31 0.33 Tax Rate 25.78% 28.32% 25.77% 30.00% 26.13% 27.52% 34.76% 3.55% 39.57% 28.18% 34.38% PAT 6.96 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 0.79 0.63 PAT before Minority Interest 6.96 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 0.79 0.63 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.29% 5.16% 3.97% 2.12% 1.84% 1.61% 2.00% 3.00% 1.69% 1.55% 1.40% PAT Growth -5.43% 50.52% 85.71% 58.90% 3.82% 28.69% -25.15% 44.25% 43.04% 25.40% EPS 0.84 0.87 0.58 0.31 0.20 0.19 0.15 0.20 0.14 0.10 0.08

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 43.84 36.57 32.46 29.87 28.24 26.67 16.37 14.74 13.61 8.57 Share Capital 16.60 16.60 4.15 4.15 4.15 4.15 3.20 1.60 1.60 1.26 Total Reserves 27.25 19.98 28.31 25.72 24.09 22.52 13.17 13.14 12.01 7.31 Non-Current Liabilities 2.08 2.50 5.21 4.92 2.63 2.55 10.93 4.39 0.63 0.69 Secured Loans 0.00 0.65 4.70 4.46 2.13 1.94 2.62 0.00 0.00 0.00 Unsecured Loans 0.25 0.25 0.25 0.25 0.25 0.25 8.22 3.70 0.00 0.00 Long Term Provisions 0.06 0.05 0.10 0.00 0.00 0.09 0.07 0.00 0.00 0.00 Current Liabilities 43.15 39.57 37.95 40.48 45.45 30.17 21.11 26.41 21.51 21.98 Trade Payables 30.99 27.10 25.35 26.40 32.52 17.52 11.88 15.36 13.15 13.18 Other Current Liabilities 1.79 1.57 4.32 6.95 2.66 2.97 1.23 0.61 0.22 0.14 Short Term Borrowings 7.85 9.06 8.11 7.12 10.27 9.69 7.90 10.10 7.89 8.41 Short Term Provisions 2.53 1.84 0.17 0.01 0.00 0.00 0.09 0.34 0.25 0.25 Total Liabilities 89.07 78.64 75.62 75.27 76.32 59.39 48.41 45.54 35.75 31.24 Net Block 21.83 18.03 15.31 12.55 12.27 6.63 6.84 7.09 7.97 7.54 Gross Block 39.35 32.39 28.89 24.36 22.43 15.37 14.57 13.77 13.47 11.85 Accumulated Depreciation 17.52 14.36 13.58 11.82 10.17 8.74 7.73 6.68 5.50 4.32 Non Current Assets 22.91 19.65 17.14 18.63 17.13 13.69 10.25 8.72 9.51 7.90 Capital Work in Progress 0.07 0.00 0.00 2.28 0.90 4.37 2.76 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.11 0.15 0.15 0.24 0.29 0.51 1.04 0.33 Long Term Loans & Adv. 0.85 1.54 1.72 3.59 3.77 2.46 0.36 1.10 0.50 0.03 Other Non Current Assets 0.16 0.07 0.00 0.06 0.05 0.00 0.00 0.01 0.00 0.00 Current Assets 66.17 59.01 58.48 56.64 59.18 45.69 38.16 36.83 26.23 23.34 Current Investments 0.00 0.00 1.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 19.70 18.11 14.55 18.26 16.07 14.91 10.14 9.17 8.17 7.62 Sundry Debtors 36.09 30.39 27.42 23.89 29.07 17.01 18.12 19.54 7.37 6.03 Cash & Bank 2.18 2.34 2.83 1.42 0.61 0.81 0.71 0.66 1.82 1.34 Other Current Assets 8.20 0.38 0.52 0.40 13.43 12.96 9.19 7.46 8.87 8.35 Short Term Loans & Adv. 7.91 7.78 12.10 12.67 12.99 12.60 8.88 7.21 8.48 7.70 Net Current Assets 23.02 19.43 20.53 16.16 13.74 15.52 17.05 10.42 4.73 1.37 Total Assets 89.08 78.66 75.62 75.27 76.31 59.38 48.41 45.55 35.74 31.24

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 8.17 5.86 -11.31 0.97 4.94 5.10 -3.22 -3.73 -0.32 2.73 PBT 10.10 6.48 3.68 2.22 2.18 1.87 1.69 1.87 1.10 0.96 Adjustment 2.71 2.52 2.57 2.14 1.86 2.15 2.46 1.94 1.83 1.25 Changes in Working Capital -2.15 -1.34 -16.63 -2.81 1.49 1.64 -6.56 -6.96 -2.87 0.81 Cash after chg. in Working capital 10.66 7.66 -10.38 1.54 5.53 5.66 -2.42 -3.15 0.06 3.01 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.50 -1.79 -0.93 -0.54 -0.55 -0.55 -0.49 -0.58 -0.38 -0.28 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 -0.03 -0.04 -0.02 -0.32 0.00 0.00 0.00 Cash From Investing Activity -6.60 -1.76 -16.96 -3.08 -4.43 -4.98 -2.81 0.32 -2.15 -3.88 Net Fixed Assets -7.03 -3.50 -2.25 -3.31 -3.59 -2.41 -3.56 -0.30 -1.62 -4.24 Net Investments 0.00 1.17 -1.02 0.00 0.09 0.05 0.22 0.53 -0.71 0.25 Others 0.43 0.57 -13.69 0.23 -0.93 -2.62 0.53 0.09 0.18 0.11 Cash from Financing Activity -1.82 -5.77 18.28 2.60 -0.55 -0.62 5.80 2.25 2.95 2.29 Net Cash Inflow / Outflow -0.25 -1.67 -9.99 0.48 -0.04 -0.50 -0.23 -1.17 0.48 1.14 Opening Cash & Equivalents 1.17 2.83 0.00 0.16 0.21 0.71 0.66 1.82 1.34 0.20 Closing Cash & Equivalent 0.91 1.17 -9.99 0.65 0.16 0.21 0.43 0.66 1.82 1.34

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 5.28 4.41 19.55 18.00 68.05 64.27 51.16 92.15 85.09 68.03 ROA 8.63% 6.24% 3.43% 2.15% 2.31% 2.26% 3.47% 2.78% 2.36% 2.54% ROE 18.01% 13.94% 8.31% 5.61% 5.72% 5.67% 10.47% 7.97% 7.14% 9.23% ROCE 21.88% 15.09% 10.13% 7.66% 7.79% 9.05% 9.39% 10.86% 10.01% 11.37% Fixed Asset Turnover 3.91 3.95 4.60 3.79 5.17 4.13 4.04 4.90 4.03 4.61 Receivable days 86.40 87.18 76.51 109.06 86.09 103.77 120.17 73.64 47.94 33.70 Inventory Days 49.13 49.25 48.92 70.69 57.88 74.02 61.63 47.46 56.52 49.80 Payable days 120.01 135.32 119.00 187.40 94.07 94.52 101.11 88.47 110.83 95.46 Cash Conversion Cycle 15.53 1.11 6.44 -7.66 49.90 83.26 80.69 32.63 -6.38 -11.96 Total Debt/Equity 0.18 0.29 0.46 0.46 0.48 0.47 1.18 0.94 0.58 0.98 Interest Cover 14.52 10.79 5.02 3.09 3.22 2.23 2.27 3.21 2.34 2.56

Top Investors:

ravi goyal (huf) .

vijaygopal parasram atal

escorp asset management limited

sanjay narendra bansal

Annual Reports:

News Update:

Medico Remedies - Quarterly Results
12th Feb 2024, 16:29 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback